Answers are grounded in this paper and cite their sources.
Ischemic stroke remains a major cause of mortality and long-term disability, and secondary injury after reperfusion is driven by oxidative stress, mitochondrial dysfunction, blood–brain barrier disruption, regulated cell death, and neuroinflammation. Ferroptosis, an iron-dependent form of lipid peroxidation-driven cell death, has emerged as a key mechanism linking metabolic failure to inflammatory amplification in the ischemic brain. After cerebral ischemia–reperfusion, disturbed iron homeostasis, increased transferrin receptor (TFRC)-mediated iron uptake, impaired ferroportin (FPN)-dependent iron export, mitochondrial reactive oxygen species (ROS) production, and acyl-CoA synthetase long-chain family member 4 (ACSL4)/arachidonate 15-lipoxygenase (ALOX15)-dependent lipid remodeling promote lipid peroxide accumulation, whereas collapse of the solute carrier family 7 member 11 (SLC7A11)/glutathione (GSH)/glutathione peroxidase 4 (GPX4) axis weakens anti-ferroptotic defense. Ferroptotic neurons and endothelial cells release oxidized lipids, high mobility group box 1 (HMGB1), mitochondrial components, and other damage-associated molecular patterns (DAMPs) that activate microglia, NLR family pyrin domain containing 3 (NLRP3) inflammasome signaling, and inflammatory cytokine networks. Conversely, NLRP3-dependent cytokines, microglial ROS and nitric oxide, and the inflammatory milieu can further disrupt iron handling, impair antioxidant defenses, damage mitochondria, and enhance lipid peroxidation, thereby increasing ferroptotic susceptibility. This bidirectional feed-forward loop aggravates neurovascular unit injury, blood–brain barrier breakdown, hemorrhagic transformation, and neurological dysfunction. This review integrates current evidence on both directions of ferroptosis-inflammation crosstalk and discusses therapeutic opportunities targeting iron metabolism, lipid peroxidation, antioxidant defense, mitochondrial dysfunction, inflammasome activation, and microglial responses to improve neurovascular protection beyond reperfusion therapy.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: